title: Human hybrid NOTES transvaginal sleeve gastrectomy: initial experience.
abstract: Laparoscopic sleeve gastrectomy is gaining popularity as a treatment of morbid obesity. It is a relatively new procedure with a postoperative follow-up not exceeding 5 years. The natural orifice transluminal endoscopic surgical procedures are also gaining in popularity, and we are now experiencing the first transition from animal to human trials. We describe the first sleeve gastrectomy surgery for morbid obesity using the vagina as the natural orifice in the form of a hybrid natural orifice transluminal endoscopic surgery transvaginal sleeve gastrectomy, including the short-term outcomes and complications.
authors.affiliation: Bariatric Surgery, Gastro Obeso Center, São Paulo, Brazil.
authors.forename: Almino Cardoso
authors.initials: AC
authors.lastname: Ramos
authors.forename: Natan
authors.initials: N
authors.lastname: Zundel
authors.forename: Manoel Galvao
authors.initials: MG
authors.lastname: Neto
authors.forename: Majed
authors.initials: M
authors.lastname: Maalouf
mesh_terms: D000328:Adult; D050110:Bariatric Surgery / Q000379:methods*; D019723:Endoscopes; D004724:Endoscopy / Q000379:methods*; D004867:Equipment Design; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D005743:Gastrectomy / Q000295:instrumentation*; D006801:Humans; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D016896:Treatment Outcome; D014621:Vagina